Centene Corp. Share Price: CNC (Centene Corp.) Stock Price Today & Updates | INDmoney

Question 1

What is Centene Corp. share price today?

Accepted Answer

Centene Corp. (CNC) share price today is {{live_price}}.

Question 2

Can Indians buy Centene Corp. shares?

Accepted Answer

Yes, Indians can invest in the Centene Corp. (CNC) from India.

With INDmoney, you can buy Centene Corp. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Centene Corp. at zero transaction cost.

Question 3

How can I buy Centene Corp. shares from India?

Accepted Answer

It is very easy to buy Centene Corp. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Centene Corp. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Centene Corp. with INDmoney app.

Question 5

What are the documents required to start investing in Centene Corp. stocks?

Accepted Answer

To start investing in Centene Corp., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Centene Corp.

Accepted Answer

Today’s highest price of Centene Corp. (CNC) is {{1_rba_end}}.

Today’s lowest price of Centene Corp. (CNC) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Centene Corp.

Accepted Answer

Today's market capitalisation of Centene Corp. CNC is 40.8B

Question 8

What is the 52 Week High and Low Range of Centene Corp.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Centene Corp. is down from its 52 Week High?

Accepted Answer

Centene Corp. (CNC) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Centene Corp. is up from its 52 Week low?

Accepted Answer

Centene Corp. (CNC) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Centene Corp.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Centene Corp.

Accepted Answer

Ms. Sarah M. London is the current Chief Executive Officer (CEO) of Centene Corp..

Period	Centene Corp.	Sector (Health Care)	S&P500
3 Months	3.59%	1.7%	3.6%
6 Months	10.89%	11.3%	21.1%
1 Year	9.96%	5.4%	24.6%
3 Years	15.44%	13.9%	21.3%

Market Capitalization	40.8B
Book Value	$48.35
Earnings Per Share (EPS)	4.95
PE Ratio	15.39
PEG Ratio	0.68
Wall Street Target Price	90.0

Profit Margin	1.91%
Operating Margin TTM	0.77%

Return On Assets TTM	3.7%
Return On Equity TTM	10.75%

Revenue TTM	141.3B
Revenue Per Share TTM	260.01
Quarterly Revenue Growth YOY	5.6000000000000005%
Gross Profit TTM	24.5B
EBITDA	6.1B
Diluted Eps TTM	4.95
Quarterly Earnings Growth YOY	-0.32

Centene Corp. (CNC)

Increasing Revenue

Decreasing Net Profit

Vs CI

Vs CI

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	6.77
EPS Estimate Next Year	7.57
EPS Estimate Current Quarter	0.43
EPS Estimate Next Quarter	2.12

	FY18	Y/Y Change
Revenue	60.1B	↑ 24.25%
Net Income	900.0M	↑ 8.7%
Net Profit Margin	1.5%	↓ 0.21%

	FY19	Y/Y Change
Revenue	74.6B	↑ 24.16%
Net Income	1.3B	↑ 46.78%
Net Profit Margin	1.77%	↑ 0.27%

	FY20	Y/Y Change
Revenue	111.1B	↑ 48.87%
Net Income	1.8B	↑ 36.87%
Net Profit Margin	1.63%	↓ 0.14%

	FY21	Y/Y Change
Revenue	126.0B	↑ 13.38%
Net Income	1.3B	↓ 25.5%
Net Profit Margin	1.07%	↓ 0.56%

	FY22	Y/Y Change
Revenue	144.5B	↑ 14.74%
Net Income	1.2B	↓ 10.76%
Net Profit Margin	0.83%	↓ 0.24%

	FY23	Y/Y Change
Revenue	154.0B	↑ 6.54%
Net Income	2.7B	↑ 124.79%
Net Profit Margin	1.75%	↑ 0.92%

	Q3 FY22	Q/Q Change
Revenue	35.9B	↓ 0.2%
Net Income	738.0M	↓ 531.58%
Net Profit Margin	2.06%	↑ 2.54%

	Q4 FY22	Q/Q Change
Revenue	35.6B	↓ 0.85%
Net Income	-219.0M	↓ 129.67%
Net Profit Margin	-0.62%	↓ 2.68%

	Q1 FY23	Q/Q Change
Revenue	38.9B	↑ 9.36%
Net Income	1.1B	↓ 615.98%
Net Profit Margin	2.91%	↑ 3.53%

	FY18	Y/Y Change
Total Assets	30.9B	↑ 41.39%
Total Liabilities	19.9B	↑ 32.71%

	FY19	Y/Y Change
Total Assets	41.0B	↑ 32.66%
Total Liabilities	28.3B	↑ 42.38%

	FY20	Y/Y Change
Total Assets	68.7B	↑ 67.63%
Total Liabilities	42.8B	↑ 51.07%

	FY21	Y/Y Change
Total Assets	78.4B	↑ 14.05%
Total Liabilities	51.4B	↑ 20.1%

	Q2 FY23	Q/Q Change
Revenue	37.6B	↓ 3.29%
Net Income	1.1B	↓ 6.37%
Net Profit Margin	2.81%	↓ 0.1%

	Q3 FY23	Q/Q Change
Revenue	38.0B	↑ 1.15%
Net Income	469.0M	↓ 55.67%
Net Profit Margin	1.23%	↓ 1.58%

	Q4 FY23	Q/Q Change
Revenue	39.5B	↑ 3.73%
Net Income	45.0M	↓ 90.41%
Net Profit Margin	0.11%	↓ 1.12%

	FY18	Y/Y Change
Operating Cash Flow	1.2B	↓ 17.13%
Investing Cash Flow	-4.6B	↑ 262.45%
Financing Cash Flow	4.6B	↓ 5724.39%

	FY19	Y/Y Change
Operating Cash Flow	1.5B	↑ 20.18%
Investing Cash Flow	-1.5B	↓ 66.59%
Financing Cash Flow	6.8B	↑ 48.14%

	FY20	Y/Y Change
Operating Cash Flow	5.5B	↑ 271.07%
Investing Cash Flow	-7.0B	↑ 353.98%
Financing Cash Flow	260.0M	↓ 96.19%

	FY21	Y/Y Change
Operating Cash Flow	4.2B	↓ 23.59%
Investing Cash Flow	-3.3B	↓ 52.57%
Financing Cash Flow	1.4B	↑ 423.85%

	FY22	Y/Y Change
Operating Cash Flow	6.3B	↑ 48.89%
Investing Cash Flow	-2.9B	↓ 11.46%
Financing Cash Flow	-4.2B	↓ 408.15%

	Q3 FY22	Q/Q Change
Operating Cash Flow	3.3B	↓ 0.66%
Investing Cash Flow	3.0M	↓ 100.4%
Financing Cash Flow	-1.5B	↑ 204.73%

	Q4 FY22	Q/Q Change
Operating Cash Flow	-1.6B	↓ 147.3%
Investing Cash Flow	-2.9B	↓ 97466.67%
Financing Cash Flow	-1.7B	↑ 16.95%

	Q1 FY23	Q/Q Change
Operating Cash Flow	4.3B	↓ 370.88%
Investing Cash Flow	-253.0M	↓ 91.34%
Financing Cash Flow	-183.0M	↓ 89.43%

	Q2 FY23	Q/Q Change
Operating Cash Flow	2.5B	↓ 40.36%
Investing Cash Flow	-424.0M	↑ 67.59%
Financing Cash Flow	-750.0M	↑ 309.84%

	Q3 FY23	Q/Q Change
Operating Cash Flow	1.0B	↓ 59.9%
Investing Cash Flow	-242.0M	↓ 42.92%
Financing Cash Flow	-524.0M	↓ 30.13%

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Centene Corp.	-1.14%	10.89%	9.96%	15.44%	51.68%
The Cigna Corp	-0.92%	15.92%	38.85%	41.26%	124.65%
Unitedhealth Group Incorporated	0.29%	-8.09%	-0.94%	23.1%	111.14%
Cvs Health Corporation	-14.19%	-1.11%	-7.0%	-10.53%	27.32%
Elevance Health, Inc	4.58%	18.59%	15.81%	41.38%	108.56%

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Centene Corp.	Buy	$40.8B	51.68%	15.39	1.91%
The Cigna Corp	Buy	$100.0B	124.65%	20.28	2.65%
Unitedhealth Group Incorporated	Buy	$447.3B	111.14%	29.68	4.05%
Cvs Health Corporation	Buy	$86.3B	27.32%	10.59	2.34%
Elevance Health, Inc	Buy	$123.9B	108.56%	20.12	3.64%

Organization	Centene Corp.
Employees	67700
CEO	Ms. Sarah M. London
Industry	Health Services